News & Updates

Show Multimedia Only

Colchicine beneficial in treatment of myopericarditis

01 Feb 2024

In patients who have had a first attack of pericarditis with evidence of myocardial involvement, treatment with colchicine is safe and helps reduce the risk of recurrence, according to a study.

Colchicine beneficial in treatment of myopericarditis

01 Feb 2024

Certain lupus patients prone to flares after COVID-19 vaccination

01 Feb 2024

Among Asian patients with systemic lupus erythematosus (SLE), those who are younger, male, from ethnic minority backgrounds, and have suboptimal disease control at time of vaccination are at increased risk of flares following mRNA COVID-19 vaccination.

Certain lupus patients prone to flares after COVID-19 vaccination

01 Feb 2024

Oxathridine linked to pseudohallucinations

01 Feb 2024

Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist, results in some serious adverse events (AEs), including orthostatic hypotension and pseudohallucinations in healthy male volunteers, results of a study have shown.

Oxathridine linked to pseudohallucinations

01 Feb 2024

Larsucosterol for hepatitis proves safety in phase IIa trial

01 Feb 2024 by

Treatment with larsucosterol is safe and well tolerated in patients with alcohol-associated hepatitis (AH), as shown in a recent study.

Larsucosterol for hepatitis proves safety in phase IIa trial

01 Feb 2024

Glaucoma surgery linked to incidence of early endophthalmitis

01 Feb 2024

The incidence of early endophthalmitis was higher for both glaucoma and combined cataract/glaucoma surgeries than for cataract surgery alone, reveals a study. The incidence was highest among tube shunts.

Glaucoma surgery linked to incidence of early endophthalmitis

01 Feb 2024

Social robot holds promise in autism screening

01 Feb 2024 by

A social robot named HUMANE holds promise in screening for autism by detecting children's eye gaze during storytelling sessions, researchers from the Chinese University of Hong Kong (CUHK) have reported.

Social robot holds promise in autism screening

01 Feb 2024

Physical activity boosts mental health in young people with neurodevelopmental disorders

01 Feb 2024

In children and adolescents with different types of neurodevelopmental disorders, physical activity interventions exert beneficial effects on mental health, including cognitive function, psychological well-being, internalizing, and externalizing problems, according to the results of a meta-analysis.

Physical activity boosts mental health in young people with neurodevelopmental disorders

01 Feb 2024

IN THE HEART OF DATA: Exploring Patient Characteristics in the MY-HF Registry and Improving the Use of Combination Drug Therapy

01 Feb 2024

Heart failure (HF) poses a growing health challenge, impacting over 26 million people worldwide. Recently published in ESC Heart Failure, the MY-HF Registry stands as the first Malaysian multicenter, observational, 3-year prospective study of 2,717 Malaysian patients admitted for acute HF (New York Heart Association [NYHA] class II‒IV) from 18 participating hospitals across Malaysia. These hospitals include those under the Ministry of Health and Ministry of Higher Education, the National Heart Institute and a private cardiac hospital within the country. The MY-HF Registry, initiated by the National Heart Association of Malaysia, sheds light on the baseline characteristics, treatment patterns and outcomes of patients during their index hospitalisation for HF.

IN THE HEART OF DATA: Exploring Patient Characteristics in the MY-HF Registry and Improving the Use of Combination Drug Therapy

01 Feb 2024

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

31 Jan 2024

In the treatment of uncomplicated gram-negative bacteraemia, switching to oral antibiotics within 4 days appears to be effective, with the all-cause mortality risk comparable to that of continued intravenous (IV) antibiotic treatment, according to a study.

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

31 Jan 2024

Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC

31 Jan 2024 by

A 52-week course of intensified androgen-deprivation therapy (ADT) appears to extend prostate-specific antigen progression-free survival (PSA-PFS) in patients with biochemically recurrent prostate cancer (BRPC) compared with ADT alone, without prolonging time to testosterone recovery, according to the phase III open-label PRESTO trial.

Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC

31 Jan 2024

News & Updates

Filter by Specialty:

Specialty:

Colchicine beneficial in treatment of myopericarditis

Colchicine beneficial in treatment of myopericarditis

Certain lupus patients prone to flares after COVID-19 vaccination

Certain lupus patients prone to flares after COVID-19 vaccination

Oxathridine linked to pseudohallucinations

Oxathridine linked to pseudohallucinations

Larsucosterol for hepatitis proves safety in phase IIa trial

Larsucosterol for hepatitis proves safety in phase IIa trial

Glaucoma surgery linked to incidence of early endophthalmitis

Glaucoma surgery linked to incidence of early endophthalmitis

Social robot holds promise in autism screening

Social robot holds promise in autism screening

Physical activity boosts mental health in young people with neurodevelopmental disorders

Physical activity boosts mental health in young people with neurodevelopmental disorders

IN THE HEART OF DATA: Exploring Patient Characteristics in the MY-HF Registry and Improving the Use of Combination Drug Therapy

IN THE HEART OF DATA: Exploring Patient Characteristics in the MY-HF Registry and Improving the Use of Combination Drug Therapy

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC

Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC